Maxim Sorokin
Overview
Explore the profile of Maxim Sorokin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1037
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sorokin M, Lyadov V, Suntsova M, Garipov M, Semenova A, Popova N, et al.
Front Mol Biosci
. 2025 Feb;
11:1448792.
PMID: 39906487
Gene fusion events result in chimeric proteins that are frequently found in human cancers. Specific targeted therapies are available for several types of cancer fusions including receptor tyrosine kinase gene...
2.
Zakharova G, Suntsova M, Rabushko E, Mohammad T, Drobyshev A, Seryakov A, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594806
Background: In clinical practice, various methods are used to identify gene rearrangements in tumor samples, ranging from "classic" techniques, such as IHC, FISH, and RT-qPCR, to more advanced highly multiplexed...
3.
Luppov D, Sorokin M, Zolotovskaya M, Sekacheva M, Suntsova M, Zakharova G, et al.
Biochemistry (Mosc)
. 2024 Nov;
89(10):1803-1822.
PMID: 39523117
Taxanes are one of the most widely used classes of breast cancer (BC) therapeutics. Despite the long history of clinical usage, the molecular mechanisms of their action and cancer resistance...
4.
Raevskiy M, Sorokin M, Emelianova A, Zakharova G, Poddubskaya E, Zolotovskaia M, et al.
Biochemistry (Mosc)
. 2024 Jun;
89(4):737-746.
PMID: 38831509
Identification of genes and molecular pathways with congruent profiles in the proteomic and transcriptomic datasets may result in the discovery of promising transcriptomic biomarkers that would be more relevant to...
5.
Zolotovskaia M, Kovalenko M, Pugacheva P, Tkachev V, Simonov A, Sorokin M, et al.
Proteomes
. 2023 Sep;
11(3).
PMID: 37755705
Individual gene expression and molecular pathway activation profiles were shown to be effective biomarkers in many cancers. Here, we used the human interactome model to algorithmically build 7470 molecular pathways...
6.
Borisov N, Tkachev V, Simonov A, Sorokin M, Kim E, Kuzmin D, et al.
Front Mol Biosci
. 2023 Sep;
10:1237129.
PMID: 37745690
Co-normalization of RNA profiles obtained using different experimental platforms and protocols opens avenue for comprehensive comparison of relevant features like differentially expressed genes associated with disease. Currently, most of bioinformatic...
7.
Kovaleva O, Sorokin M, Egorova A, Petrenko A, Shelekhova K, Gratchev A
Front Oncol
. 2023 Mar;
13:1078029.
PMID: 36910627
Tumor cells communication with tumor associated macrophages is a highly important factor of tumor malignant potential development. For a long time, studies of this interaction were focused on a cytokine-...
8.
Pustovalova M, Malakhov P, Guryanova A, Sorokin M, Suntsova M, Buzdin A, et al.
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36769365
Radioresistance is a major obstacle for the successful therapy of many cancers, including non-small cell lung cancer (NSCLC). To elucidate the mechanism of radioresistance of NSCLC cells and to identify...
9.
Sorokin M, Zolotovskaia M, Nikitin D, Suntsova M, Poddubskaya E, Glusker A, et al.
BMC Cancer
. 2022 Nov;
22(1):1113.
PMID: 36316649
Background: Overall survival of advanced colorectal cancer (CRC) patients remains poor, and gene expression analysis could potentially complement detection of clinically relevant mutations to personalize CRC treatments. Methods: We performed...
10.
Kamashev D, Shaban N, Suntsova M, Raevskiy M, Efimov V, Moisseev A, et al.
Biomedicines
. 2022 Aug;
10(8).
PMID: 36009461
Trastuzumab, a HER2-targeted antibody, is widely used for targeted therapy of HER2-positive breast cancer (BC) patients; yet, not all of them respond to this treatment. We investigated here whether trastuzumab...